NCT04998604 EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients Status COMPLETED Phase PHASE4
NCT04869436 Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis Status RECRUITING Phase PHASE4
NCT04851964 Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal Polyposis Status COMPLETED Phase PHASE3
NCT04823585 Aggravated Airway Inflammation: Research on Biological Treatment (Mepolizumab) Status COMPLETED Phase PHASE4
NCT04783389 A Study to Evaluate CBP-201, Rademikibart, in Adult Patients With Chronic Rhinosinusitis With Nasal Polyps Status TERMINATED Phase PHASE2
NCT04583501 Preclinical Studies of Omalizumab in Chronic Rhinosinusitis With Nasal Polyposis Status COMPLETED Phase EARLY_PHASE1
NCT04286542 Mediators in Nasal Hyperreactivity in Allergic Rhinitis and Chronic Rhinosinusitis Status UNKNOWN Phase NA
NCT04267042 Comparing Budesonide Via MAD or INSI Prospective Cohort Study Status UNKNOWN Phase EARLY_PHASE1
NCT04147013 Effect of Celecoxib on Postoperative Analgesia and Disease Severity in AERD Patients with CRS Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT04104594 Olfaction and Inflammation in Chronic Rhinosinusitis With Nasal Polyps Status TERMINATED Phase NA
NCT02743871 Study Of PF-06817024 In Healthy Subjects, In Patients With Chronic Rhinosinusitis With Nasal Polyps And in Patients With Atopic Dermatitis Status COMPLETED Phase PHASE1
NCT02668861 Effect of Oral Vitamin D3 on Chronic Rhinosinusitis Treatment in Adults With Lower Vitamin D Levels Status UNKNOWN Phase PHASE3
NCT02170337 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Chronic Rhinosinusitis With Nasal Polyps Status COMPLETED Phase PHASE1